Apyx Medical Inc (APYX) - Total Assets
Based on the latest financial reports, Apyx Medical Inc (APYX) holds total assets worth $63.02 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check APYX cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Apyx Medical Inc - Total Assets Trend (1995–2025)
This chart illustrates how Apyx Medical Inc's total assets have evolved over time, based on quarterly financial data. Check cash flow quality index of Apyx Medical Inc to evaluate the quality of earnings relative to operating cash generation.
Apyx Medical Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Apyx Medical Inc's total assets of $63.02 Million consist of 87.5% current assets and 12.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 47.5% |
| Accounts Receivable | $16.78 Million | 25.1% |
| Inventory | $8.60 Million | 12.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1995–2025)
This chart illustrates how Apyx Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see APYX company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Apyx Medical Inc's current assets represent 87.5% of total assets in 2025, an increase from 46.7% in 1995.
- Cash Position: Cash and equivalents constituted 47.5% of total assets in 2025, up from 4.6% in 1995.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 14.0% in 1995.
- Asset Diversification: The largest asset category is accounts receivable at 25.1% of total assets.
Apyx Medical Inc Competitors by Total Assets
Key competitors of Apyx Medical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
China | CN¥2.00 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
|
China | CN¥3.54 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
Apyx Medical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.80 | 5.45 | 5.73 |
| Quick Ratio | 4.79 | 4.64 | 5.24 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $45.35 Million | $42.34 Million | $50.84 Million |
Apyx Medical Inc - Advanced Valuation Insights
This section examines the relationship between Apyx Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 15.04 |
| Latest Market Cap to Assets Ratio | 2.60 |
| Asset Growth Rate (YoY) | 3.1% |
| Total Assets | $66.84 Million |
| Market Capitalization | $173.78 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Apyx Medical Inc's assets at a significant premium (2.60x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Apyx Medical Inc's assets grew by 3.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Apyx Medical Inc (1995–2025)
The table below shows the annual total assets of Apyx Medical Inc from 1995 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $66.84 Million | +3.08% |
| 2024-12-31 | $64.84 Million | -18.17% |
| 2023-12-31 | $79.24 Million | +53.05% |
| 2022-12-31 | $51.77 Million | -24.66% |
| 2021-12-31 | $68.72 Million | -7.27% |
| 2020-12-31 | $74.11 Million | -12.48% |
| 2019-12-31 | $84.68 Million | -11.44% |
| 2018-12-31 | $95.61 Million | +208.54% |
| 2017-12-31 | $30.99 Million | -11.74% |
| 2016-12-31 | $35.11 Million | +11.64% |
| 2015-12-31 | $31.45 Million | +26.64% |
| 2014-12-31 | $24.83 Million | -25.15% |
| 2013-12-31 | $33.18 Million | +17.72% |
| 2012-12-31 | $28.18 Million | -0.20% |
| 2011-12-31 | $28.24 Million | +1.63% |
| 2010-12-31 | $27.79 Million | +0.73% |
| 2009-12-31 | $27.58 Million | +7.00% |
| 2008-12-31 | $25.78 Million | +36.97% |
| 2007-12-31 | $18.82 Million | +12.80% |
| 2006-12-31 | $16.69 Million | +41.75% |
| 2005-12-31 | $11.77 Million | +6.82% |
| 2004-12-31 | $11.02 Million | +19.33% |
| 2003-12-31 | $9.23 Million | +8.62% |
| 2002-12-31 | $8.50 Million | -0.91% |
| 2001-12-31 | $8.58 Million | +8.40% |
| 2000-12-31 | $7.91 Million | +7.76% |
| 1999-12-31 | $7.34 Million | -31.11% |
| 1998-12-31 | $10.66 Million | +177.77% |
| 1997-12-31 | $3.84 Million | -1.57% |
| 1996-12-31 | $3.90 Million | +8.28% |
| 1995-12-31 | $3.60 Million | -- |
About Apyx Medical Inc
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and … Read more